2026-2030年全球人造器官市場

全球人造器官市場預計將從 2025 年到 2030 年成長至 170.53 億美元，預測期內複合年成長率為 9.2%。

這份關於全球人造器官市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。市場成長的促進因素包括政府投入的增加、數位智慧技術的融合以及穿戴式醫療設備的普及。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場數據及區域分析，以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，穿戴式人工腎臟的興起將是未來幾年全球人工器官市場成長的關鍵促進因素之一。此外，神經介面技術的整合和生物列印支架解決方案的擴展預計也將產生可觀的市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球人工器官市場
• 基於使用情況的細分市場分析，2020-2024 年
• 產品細分市場分析，2020-2024 年
• 2020年至2024年最終用戶細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球人工器官市場
• 地緣政治衝突的影響：全球人造器官市場

第7章：五力分析

第8章 市場區隔：依用途

• 比較：依使用情況
• 嵌入式
• 體外
• 市場機會：依用途分類

第9章 市場區隔：依產品

• 比較：按產品
• 人工心臟
• 人工腎臟
• 人工電子耳
• 人工胰臟
• 市場機會：依產品分類

第10章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院和診所
• 門診手術中心
• 研究和學術機構
• 市場機會：依最終用戶分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • UAE
  • 土耳其
  • 阿根廷
  • 南非
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 中斷狀況
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Abbott Laboratories
• Advanced Bionics AG
• B.Braun SE
• Baxter International Inc.
• Berlin Heart GmbH
• Cochlear Ltd.
• Fresenius Medical Co. KGaA
• Getinge AB
• LivaNova PLC
• MED EL Medical Electronics
• Medtronic Plc
• Nipro Corp.
• Oticon Medical AS
• Terumo Corp.
• Toray Industries Inc.

第16章附錄

The global artificial organs market is forecasted to grow by USD 17005.3 mn during 2025-2030, accelerating at a CAGR of 9.2% during the forecast period. The report on the global artificial organs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of government funding initiatives, integration of digital intelligence technologies, shift toward wearable medical devices.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global artificial organs market is segmented as below:

By Usage

• Implantable
• Extracorporeal

By Product

• Artificial heart
• Artificial kidney
• Cochlear implants
• Artificial pancreas

By End-User

• Hospitals and clinics
• Ambulatory surgical centers
• Research and academic institutes

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rise of wearable artificial kidneys as one of the prime reasons driving the global artificial organs market growth during the next few years. Also, integration of neural interface technologies and expansion of bioprinting scaffold solutions will lead to sizable demand in the market.

The report on the global artificial organs market covers the following areas:

• Global artificial organs market sizing
• Global artificial organs market forecast
• Global artificial organs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global artificial organs market vendors that include Abbott Laboratories, Advanced Bionics AG, B.Braun SE, Baxter International Inc., Berlin Heart GmbH, Cochlear Ltd., Diabeloop SA, Envoy Medical Inc., Fresenius Medical Co. KGaA, Getinge AB, Insulet Corp., LivaNova PLC, MED EL Medical Electronics, Medtronic Plc, Nipro Corp., Oticon Medical AS, Outset Medical Inc., Quanta Dialysis Technologies Ltd., Terumo Corp., Toray Industries Inc.. Also, the global artificial organs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Usage
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Artificial Organs Market 2020 - 2024
  • Historic Market Size - Data Table on Global Artificial Organs Market 2020 - 2024 ($ million)
• 5.2 Usage segment analysis 2020 - 2024
  • Historic Market Size - Usage Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Artificial Organs Market
• 6.2 Impact of geopolitical conflicts on Global Artificial Organs Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Usage

• 8.1 Market segments
• 8.2 Comparison by Usage
• 8.3 Implantable - Market size and forecast 2025-2030
• 8.4 Extracorporeal - Market size and forecast 2025-2030
• 8.5 Market opportunity by Usage
  • Market opportunity by Usage ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 Artificial heart - Market size and forecast 2025-2030
• 9.4 Artificial kidney - Market size and forecast 2025-2030
• 9.5 Cochlear implants - Market size and forecast 2025-2030
• 9.6 Artificial pancreas - Market size and forecast 2025-2030
• 9.7 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospitals and clinics - Market size and forecast 2025-2030
• 10.4 Ambulatory surgical centers - Market size and forecast 2025-2030
• 10.5 Research and academic institutes - Market size and forecast 2025-2030
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 South Africa - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Expansion of government funding initiatives
  • Integration of digital intelligence technologies
  • Shift toward wearable medical devices
• 13.2 Market challenges
  • Biocompatibility and complex material integration
  • Regulatory compliance and clinical validation
  • High costs and limited reimbursement frameworks
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Rise of wearable artificial kidneys
  • Integration of neural interface technologies
  • Expansion of bioprinting scaffold solutions

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Advanced Bionics AG
  • Advanced Bionics AG - Overview
  • Advanced Bionics AG - Product / Service
  • Advanced Bionics AG - Key offerings
  • SWOT
• 15.6 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key offerings
  • SWOT
• 15.7 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 15.8 Berlin Heart GmbH
  • Berlin Heart GmbH - Overview
  • Berlin Heart GmbH - Product / Service
  • Berlin Heart GmbH - Key offerings
  • SWOT
• 15.9 Cochlear Ltd.
  • Cochlear Ltd. - Overview
  • Cochlear Ltd. - Business segments
  • Cochlear Ltd. - Key offerings
  • Cochlear Ltd. - Segment focus
  • SWOT
• 15.10 Fresenius Medical Co. KGaA
  • Fresenius Medical Co. KGaA - Overview
  • Fresenius Medical Co. KGaA - Business segments
  • Fresenius Medical Co. KGaA - Key offerings
  • Fresenius Medical Co. KGaA - Segment focus
  • SWOT
• 15.11 Getinge AB
  • Getinge AB - Overview
  • Getinge AB - Business segments
  • Getinge AB - Key offerings
  • Getinge AB - Segment focus
  • SWOT
• 15.12 LivaNova PLC
  • LivaNova PLC - Overview
  • LivaNova PLC - Business segments
  • LivaNova PLC - Key offerings
  • LivaNova PLC - Segment focus
  • SWOT
• 15.13 MED EL Medical Electronics
  • MED EL Medical Electronics - Overview
  • MED EL Medical Electronics - Product / Service
  • MED EL Medical Electronics - Key offerings
  • SWOT
• 15.14 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.15 Nipro Corp.
  • Nipro Corp. - Overview
  • Nipro Corp. - Business segments
  • Nipro Corp. - Key offerings
  • Nipro Corp. - Segment focus
  • SWOT
• 15.16 Oticon Medical AS
  • Oticon Medical AS - Overview
  • Oticon Medical AS - Product / Service
  • Oticon Medical AS - Key offerings
  • SWOT
• 15.17 Terumo Corp.
  • Terumo Corp. - Overview
  • Terumo Corp. - Business segments
  • Terumo Corp. - Key news
  • Terumo Corp. - Key offerings
  • Terumo Corp. - Segment focus
  • SWOT
• 15.18 Toray Industries Inc.
  • Toray Industries Inc. - Overview
  • Toray Industries Inc. - Business segments
  • Toray Industries Inc. - Key news
  • Toray Industries Inc. - Key offerings
  • Toray Industries Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations